Company Filing History:
Years Active: 2005-2008
Title: Michael Stowell: Innovator in Targeted Drug Delivery
Introduction
Michael Stowell is a prominent inventor based in Fulbourn, GB. He has made significant contributions to the field of drug delivery systems, particularly in the development of methods for targeting biologically active compounds to specific cells.
Latest Patents
Stowell holds 2 patents that focus on nonporous microparticle-prodrug conjugates for the treatment of infections. His inventions provide novel methods and reagents for delivering biologically active compounds specifically to phagocytic mammalian cells. The first patent details methods for facilitating the entry of antiviral and antimicrobial drugs into these cells, targeting specific organelles within them. The second patent describes compositions containing porous microparticles impregnated with biologically active compounds, aimed at treating infections by ensuring that the drugs are activated only in cells infected by specific microorganisms.
Career Highlights
Michael Stowell is affiliated with Oregon Health & Science University, where he continues to advance research in targeted drug delivery systems. His work has the potential to significantly improve treatment outcomes for infections by enhancing the specificity and efficacy of drug delivery.
Collaborations
Stowell has collaborated with notable colleagues, including Milton Yatvin and Vincent S Gallicchio, contributing to the advancement of innovative drug delivery technologies.
Conclusion
Michael Stowell's innovative work in targeted drug delivery systems exemplifies the potential of scientific research to address critical health challenges. His patents represent a significant step forward in the treatment of infections, showcasing the importance of precision in medicine.